CARDIOVASCULAR GENOMICS
	Cambridge Healthtech Institute , Miami, Florida January 31-February 1, 2000
	The prominent position of genetics in cardiovascular research is becoming increasingly established. Researchers are broadening their scope of genetic and molecular models of cardiovascular research and are using them in both clinical and applied laboratory settings (i.e. drug design). Progress continues to be made in the understanding of in vitro and in vivo transduction, relevant genes, linkage analysis, transgenic and knock-out models as well as congenic animals. Genetics will be a turning point in reassessing existent and future tools, ranging from epidemiology to molecular targeting in cardiovascular diseases. In terms of therapeutics, gene therapy is a forthcoming opportunity even in cardiovascular diseases, already becoming a reality.
	Organized by:	Cambridge Healthtech Institute
	Deadline for Abstracts:	December 17, 1999
	Registration:	Available on-line
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: 140.239.39.137 date: November 17, 1999 21:02:36 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.